Published in Ann Gen Psychiatry on November 18, 2014
An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels. Am J Transl Res (2016) 0.76
Histamine and Immune Biomarkers in CNS Disorders. Mediators Inflamm (2016) 0.75
Altered expression of histamine signaling genes in autism spectrum disorder. Transl Psychiatry (2017) 0.75
New developments in the management of narcolepsy. Nat Sci Sleep (2017) 0.75
Hypothalamic tuberomammillary nucleus neurons: electrophysiological diversity and essential role in arousal stability. J Neurosci (2017) 0.75
The physiological action of beta-iminazolylethylamine. J Physiol (1910) 43.41
Definition and antagonism of histamine H 2 -receptors. Nature (1972) 18.58
How many drug targets are there? Nat Rev Drug Discov (2006) 14.22
Receptors mediating some actions of histamine. Br J Pharmacol Chemother (1966) 6.93
2013 Alzheimer's disease facts and figures. Alzheimers Dement (2013) 4.75
Structure of the human histamine H1 receptor complex with doxepin. Nature (2011) 3.48
Histamine in the nervous system. Physiol Rev (2008) 3.47
Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol (2002) 2.97
Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol Psychiatry (2011) 2.28
Histaminergic transmission in the mammalian brain. Physiol Rev (1991) 2.28
Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci (2002) 2.10
Histamine-sensitive adenylate cyclase in mammalian brain. Nature (1976) 1.91
Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci (2006) 1.86
The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol (2009) 1.68
Histidinaemia. Study of relation between clinical and biological findings in 7 subjects. Arch Dis Child (1972) 1.41
Dopamine D2 receptors as treatment targets in schizophrenia. Clin Schizophr Relat Psychoses (2010) 1.29
[Specific neurons for wakefulness in the posterior hypothalamus in the cat]. C R Acad Sci III (1984) 1.25
Localization of histamine H4 receptors in the central nervous system of human and rat. Brain Res (2008) 1.24
Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc Natl Acad Sci U S A (2006) 1.22
Characteristics of histamine H1-receptors in peripheral tissues labeled with [3H]mepyramine. J Pharmacol Exp Ther (1979) 1.18
Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun (2000) 1.18
Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep (2009) 1.16
Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics. Pharmacol Ther (2008) 1.16
An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis (2007) 1.15
CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep (2009) 1.13
Histamine influences body temperature by acting at H1 and H3 receptors on distinct populations of preoptic neurons. J Neurosci (2010) 1.09
Oral famotidine: a potential treatment for children with autism. Med Hypotheses (1997) 1.08
The histamine H3 receptor as a therapeutic drug target for CNS disorders. Drug Discov Today (2009) 1.06
Histamine receptors: specific ligands, receptor biochemistry, and signal transduction. Clin Allergy Immunol (2002) 1.05
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav (2009) 1.01
Role of histamine H(1) receptor in pain perception: a study of the receptor gene knockout mice. Eur J Pharmacol (2000) 1.01
Thr105Ile, a functional polymorphism of histamine N-methyltransferase, is associated with alcoholism in two independent populations. Alcohol Clin Exp Res (2005) 0.99
An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol (2000) 0.98
Histamine in neurotransmission and brain diseases. Adv Exp Med Biol (2010) 0.98
Impact of the DRY motif and the missing "ionic lock" on constitutive activity and G-protein coupling of the human histamine H4 receptor. J Pharmacol Exp Ther (2010) 0.98
Metabolic perturbance in autism spectrum disorders: a metabolomics study. J Proteome Res (2012) 0.97
Evidence for the presence of histamine H1-receptors in guinea-pig brain [proceedings]. Br J Pharmacol (1978) 0.97
Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data. Clin Neuropharmacol (1993) 0.97
Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain. Pain (2007) 0.96
Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder. CNS Drugs (2012) 0.95
Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors. Neurosci Res (2006) 0.94
Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia. Sleep Med (2011) 0.92
The rise and fall of Dimebon. Drug News Perspect (2010) 0.92
Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease. Neurosci Lett (2001) 0.90
The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish. FASEB J (2011) 0.90
Altered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases. Br J Pharmacol (2009) 0.90
The Akt/GSK-3beta axis as a new signaling pathway of the histamine H(3) receptor. J Neurochem (2007) 0.89
Medication adherence and subjective weight perception in patients with first-episode psychotic disorder. Clin Schizophr Relat Psychoses (2011) 0.89
Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release. Eur J Neurosci (2002) 0.89
JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats. Psychopharmacology (Berl) (2010) 0.87
Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J Neurochem (2002) 0.87
Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease. Neurobiol Learn Mem (2010) 0.87
Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness. Clin Neuropharmacol (2012) 0.86
Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination. Psychopharmacology (Berl) (2012) 0.86
Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: a postmortem study. Neurobiol Aging (2011) 0.86
The safety, tolerability, pharmacokinetics and cognitive effects of GSK239512, a selective histamine H₃ receptor antagonist in patients with mild to moderate Alzheimer's disease: a preliminary investigation. Curr Alzheimer Res (2013) 0.86
Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives. Br J Pharmacol (2012) 0.86
A histamine-containing neuronal system in human brain. Neuroscience (1990) 0.86
Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease -- a randomized study. Parkinsonism Relat Disord (2013) 0.86
Molecular properties and signalling pathways of the histamine H1 receptor. Clin Exp Allergy (1999) 0.85
Alterations in the histaminergic system in Alzheimer's disease: a postmortem study. Neurobiol Aging (2012) 0.85
Combinatorial roles for histamine H1-H2 and H3-H4 receptors in autoimmune inflammatory disease of the central nervous system. Eur J Immunol (2012) 0.85
JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition. Neuropharmacology (2009) 0.85
Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan. Behav Brain Res (2004) 0.85
Once-monthly paliperidone injection for the treatment of schizophrenia. Neuropsychiatr Dis Treat (2010) 0.84
A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease. Curr Alzheimer Res (2014) 0.84
Human memory Th17 cells express a functional histamine H4 receptor. Am J Pathol (2011) 0.84
Antinociceptive effects of histamine H3 receptor antagonist in the preclinical models of pain in rats and the involvement of central noradrenergic systems. Brain Res (2010) 0.84
Histamine H1 receptors in schizophrenic patients measured by positron emission tomography. Eur Neuropsychopharmacol (2005) 0.84
Dopamine-beta hydroxylase polymorphism and cocaine addiction. Behav Brain Funct (2008) 0.83
AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects. Int J Neuropsychopharmacol (2012) 0.83
Integrative role of the histaminergic system in feeding and taste perception. Front Syst Neurosci (2012) 0.83
Expression of histamine receptor genes Hrh3 and Hrh4 in rat brain endothelial cells. Br J Pharmacol (2013) 0.83
Decrease in blood histamine in drug-treated parkinsonian patients. Mol Chem Neuropathol (1991) 0.83
Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia. Int J Neuropsychopharmacol (2012) 0.83
Mechanism of H₂ histamine receptor dependent modulation of body temperature and neuronal activity in the medial preoptic nucleus. Neuropharmacology (2012) 0.83
Gene expression profiling identifies WNT7A as a possible candidate gene for decreased cancer risk in fragile X syndrome patients. Arch Med Res (2010) 0.83
Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice. Neuropsychopharmacology (2013) 0.82
Activation of the histaminergic H3 receptor induces phosphorylation of the Akt/GSK-3 beta pathway in cultured cortical neurons and protects against neurotoxic insults. J Neurochem (2009) 0.82
Niaprazine in the treatment of autistic disorder. J Child Neurol (1999) 0.81
Autistic children exhibit distinct plasma amino acid profile. Indian J Biochem Biophys (2013) 0.81
Autism diagnoses in the US rise by 30%, CDC reports. BMJ (2014) 0.81
Role of hippocampal H1 receptors in radial maze performance and hippocampal theta activity in rats. Brain Res Bull (2007) 0.80
Regulation of histamine release in rat hypothalamus and hippocampus by presynaptic galanin receptors. Peptides (1992) 0.80
Constitutive histamine H2 receptor activity regulates serotonin release in the substantia nigra. J Neurochem (2008) 0.80
First and second generation H₁ histamine receptor antagonists produce different sleep-inducing profiles in rats. Eur J Pharmacol (2012) 0.80
Presynaptic H3 autoreceptors modulate histamine synthesis through cAMP pathway. Mol Pharmacol (2002) 0.80
A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophrenia. Schizophr Bull (2014) 0.79
Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design. J Neural Transm (Vienna) (2001) 0.79
Interaction between serotonin transporter and serotonin receptor 1 B genes polymorphisms may be associated with antisocial alcoholism. Behav Brain Funct (2012) 0.79
The neglected role of histamine in Alzheimer's disease. Am J Alzheimers Dis Other Demen (2013) 0.79
The H1 histamine receptor blocker, chlorpheniramine, completely prevents the increase in REM sleep induced by immobilization stress in rats. Pharmacol Biochem Behav (2008) 0.79
Histaminergic activity in a rodent model of Parkinson's disease. Neurotox Res (2009) 0.78
Activation of histamine H3 receptors inhibits renal noradrenergic neurotransmission in anesthetized dogs. Am J Physiol Regul Integr Comp Physiol (2001) 0.78
A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia. J Alzheimers Dis (2014) 0.78
An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy. Clin Neuropharmacol (1996) 0.78
Histamine reverses a memory deficit induced in rats by early postnatal maternal deprivation. Neurobiol Learn Mem (2011) 0.78
Regulation of histamine release and synthesis in the brain by muscarinic receptors. J Neurochem (1989) 0.78
SAR110894, a potent histamine H₃-receptor antagonist, displays procognitive effects in rodents. Pharmacol Biochem Behav (2012) 0.78